Treatment and Prognosis of Vogt-Koyanagi-Harada Disease: Real-Life Experience in Long-Term Follow-Up.

Massimo AccorintiMaria Carmela SaturnoLudovico IannettiPriscilla ManniDavide MastromarinoMaria Pia Pirraglia

Published in: Journal of clinical medicine (2022)

The long-term prognosis of VKH is quite good. Intravenous corticosteroids given at the onset of VKH are more effective than oral corticosteroids. Even if it is not given immediately after symptoms onset, immunosuppressive therapy is able to reduce the incidence of sunset glow fundus and to improve the final visual prognosis.

Keyphrases

risk factors
diabetic retinopathy
depressive symptoms
physical activity
mesenchymal stem cells
sleep quality
bone marrow
cell therapy
optical coherence tomography